Clindamycin
Clindamycin is a pharmaceutical drug with 52 clinical trials. Currently 7 active trials ongoing. Historical success rate of 88.6%.
Success Metrics
Based on 31 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
8
Mid Stage
27
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.8%
31 of 37 finished
16.2%
6 ended early
7
trials recruiting
52
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Clindamycin Once a Day in Septic Abortion
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC)
Clinical Trials (52)
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Clindamycin Once a Day in Septic Abortion
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC)
Comparison Between Oral Clindamycin Vs Metronidazole for the Treatment of Abnormal Vaginal Flora in High Risk Pregnancies
Staphylococcus Aureus Network Adaptive Platform Trial
CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)
Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis
Optimal Treatment of MRSA Throat Carriers
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial
Clostridioides Difficile Controlled Human Infection Model
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS)
An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures
Rifampicin Combination Therapy Versus Monotherapy for Staphylococcal Prosthetic Joint Infection
Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections
Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy
The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 52